Trihexyphenidyl PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Trihexyphenidyl PCD pharma franchise company offering 8 WHO-GMP certified Trihexyphenidyl formulations manufactured in DCGI-approved facilities. Our range is supplied to franchise partners across India with district-wise monopoly rights.
What is Trihexyphenidyl?
Trihexyphenidyl is an anticholinergic agent that blocks central muscarinic receptors to help restore the dopamine-acetylcholine balance in the brain. It is used to manage Parkinsonism and drug-induced extrapyramidal symptoms. Learn more on PubChem.
Available Trihexyphenidyl Formulations
Our Trihexyphenidyl portfolio spans 8 formulations across the following dosage forms: Tablets. As a prescription medicine, these are supplied against valid prescriptions.
Therapeutic Applications
Trihexyphenidyl is prescribed for Parkinsons disease and drug-induced extrapyramidal side effects such as dystonia and tremor. As a prescription medicine it is used under neurologists and psychiatrists.
Why Trihexyphenidyl is a High-Potential Molecule for Distributors
Chronic neurological and psychiatric use ensures long-term, repeat demand for Trihexyphenidyl. Its role in managing antipsychotic side effects gives franchise partners steady offtake from neurology and psychiatry practices.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP and DCGI-approved manufacturing, timely supply and complete promotional inputs. With 1000+ franchise partners, we back every associate marketing our Trihexyphenidyl range with reliable support.
References
- PubChem - Trihexyphenidyl
- PubMed - Trihexyphenidyl research
Our formulations of Trihexyphenidyl find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: